Benefit risk assessment and update on the use of docetaxel in the management of breast cancer

por Alken, Scheryll, Kelly, Catherine M
Publicado 2013

Therapeutic Advances and New Directions for Triple-Negative Breast Cancer

por Andreopoulou, Eleni, Kelly, Catherine M., McDaid, Hayley M.
Publicado en Breast Care (Basel) (2017)

Overview of recent advances in metastatic triple negative breast cancer

por O'Reilly, David, Sendi, Maha Al, Kelly, Catherine M
Publicado en World J Clin Oncol (2021)

Estrogen and HER-2 Receptor Discordance Between Primary Breast Cancer and Metastasis

por Pusztai, Lajos, Viale, Giuseppe, Kelly, Catherine M., Hudis, Clifford A.
Publicado 2010

Cost-Effectiveness Analysis of Recurrence Score-Guided Treatment Using a 21-Gene Assay in Early Breast Cancer

por Tsoi, Daphne T., Inoue, Miho, Kelly, Catherine M., Verma, Sunil, Pritchard, Kathleen I.
Publicado 2010

Review of the Clinical Studies Using the 21-Gene Assay

por Kelly, Catherine M., Warner, Ellen, Tsoi, Daphne T., Verma, Sunil, Pritchard, Kathleen I.
Publicado 2010

The psychosocial determinants of quality of life in breast cancer survivors: a scoping review

por Culbertson, Michael G., Bennett, Kathleen, Kelly, Catherine M., Sharp, Linda, Cahir, Caitriona
Publicado en BMC Cancer (2020)

Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer

por Santarpia, Libero, Bottai, Giulia, Kelly, Catherine M., Győrffy, Balázs, Székely, Borbala, Pusztai, Lajos
Publicado en Oncologist (2016)

Conformational dynamics and aggregation behavior of piezoelectric diphenylalanine peptides in an external electric field

por Kelly, Catherine M., Northey, Thomas, Ryan, Kate, Brooks, Bernard R., Kholkin, Andrei, Rodriguez, Brian J., Buchete, Nicolae-Viorel
Publicado en Biophys Chem (2014)

Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study

por Kelly, Catherine M, Juurlink, David N, Gomes, Tara, Duong-Hua, Minh, Pritchard, Kathleen I, Austin, Peter C, Paszat, Lawrence F
Publicado 2010

Competing mortality risks: predicted cardiovascular disease risk versus predicted risk of breast cancer mortality in patients receiving adjuvant chemotherapy in a single Irish cent...

por Prior, Lisa, Featherstone, Hannah, O’Reilly, David, Nugent, Killian, Lim, Marvin, McCaffrey, John, Higgins, Michaela J, Kelly, Catherine M.
Publicado en Cardiooncology (2021)

“Candidatus Mycoplasma haemomacaque” and Bartonella quintana Bacteremia in Cynomolgus Monkeys

por Maggi, Ricardo G., Mascarelli, Patricia E., Balakrishnan, Nandhakumar, Rohde, Cynthia M., Kelly, Catherine M., Ramaiah, Lila, Leach, Michael W., Breitschwerdt, Edward B.
Publicado 2013

Agreement in Risk Prediction Between the 21-Gene Recurrence Score Assay (Oncotype DX®) and the PAM50 Breast Cancer Intrinsic Classifier™ in Early-Stage Estrogen Receptor–Positive B...

por Kelly, Catherine M., Bernard, Philip S., Krishnamurthy, Savitri, Wang, Bailiang, Ebbert, Mark T.W., Bastien, Roy R.L., Boucher, Kenneth M., Young, Elliana, Iwamoto, Takayuki, Pusztai, Lajos
Publicado 2012

Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer

por O´Leary, Patrick C, Penny, Sarah A, Dolan, Roisin T, Kelly, Catherine M, Madden, Stephen F, Rexhepaj, Elton, Brennan, Donal J, McCann, Amanda H, Pontén, Fredrik, Uhlén, Mathias, Zagozdzon, Radoslaw, Duffy, Michael J, Kell, Malcolm R, Jirström, Karin, Gallagher, William M
Publicado 2013

Postmortem Examination of an Aggressive Case of Medullary Thyroid Carcinoma Characterized by Catastrophic Genomic Abnormalities

por Das, Sudipto, Kelly, Deirdre, Moran, Bruce, Han, Kathleen, Mulligan, Niall, Barrett, Ciara, Buckley, Patrick G., McMahon, Peter, McCaffrey, John, Van Essen, Hendrik F., Connor, Kate, Lambrechts, Diether, Ylstra, Bauke, Gallagher, William M., O’Connor, Darran P., Kelly, Catherine M.
Publicado en JCO Precis Oncol (2017)

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers

por Bianchini, Giampaolo, Pusztai, Lajos, Karn, Thomas, Iwamoto, Takayuki, Rody, Achim, Kelly, Catherine M, Müller, Volkmar, Schmidt, Marcus, Qi, Yuan, Holtrich, Uwe, Becker, Sven, Santarpia, Libero, Fasolo, Angelica, Del Conte, Gianluca, Zambetti, Milvia, Sotiriou, Christos, Haibe-Kains, Benjamin, Symmans, W Fraser, Gianni, Luca
Publicado 2013

Virtual oncology clinics during the COVID-19 pandemic

por O’Reilly, David, Carroll, Hailey, Lucas, Mairi, Sui, Jane, Al Sendi, Maha, McMahon, David, Darwish, Waseem, McLaughlin, Ronan, Khan, Mohammed Raza, Sullivan, Hazel O, Chew, Sonya, Dennehy, Colum, Kelly, Catherine M., McCaffrey, John, Greally, Megan, Carney, Desmond, Higgins, Michaela J.
Publicado en Ir J Med Sci (2021)

Understanding and Attitudes toward Cancer Clinical Trials among Patients with a Cancer Diagnosis: National Study through Cancer Trials Ireland

por Kearns, Cathriona, Feighery, Ronan, Mc Caffrey, John, Higgins, Michaela, Smith, Martina, Murphy, Verena, O’Reilly, Seamus, Horgan, Anne M., Walshe, Janice, McDermott, Ray, Morris, Patrick G., Keane, Maccon, Martin, Michael, Murphy, Conleth, Duffy, Karen, Mihai, Alina, Armstrong, John, O’Donnell, Dearbhaile M., Gallagher, William M., Kelly, Ciara M., Kelly, Catherine M.
Publicado en Cancers (Basel) (2020)

Phase Ib Trial of Copanlisib, A Phosphoinositide-3 Kinase (PI3K) Inhibitor, with Trastuzumab in Advanced Pre-Treated HER2-Positive Breast Cancer “PantHER”

por Keegan, Niamh M., Furney, Simon J., Walshe, Janice M., Gullo, Giuseppe, Kennedy, M. John, Smith, Diarmuid, McCaffrey, John, Kelly, Catherine M., Egan, Keith, Kerr, Jennifer, Given, Mark, O’Donovan, Peter, Hernando, Andres, Teiserskiene, Ausra, Parker, Imelda, Kay, Elaine, Farrelly, Angela, Carr, Aoife, Calzaferri, Giulio, McDermott, Ray, Keane, Maccon M., Grogan, Liam, Breathnach, Oscar, Morris, Patrick G., Toomey, Sinead, Hennessy, Bryan T.
Publicado en Cancers (Basel) (2021)